Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea · Delayed Price · Currency is KRW 4,655.00
+40.00 (0.87%)
At close: Mar 27, 2026
Jin Yang Pharmaceutical Revenue
In the year 2025, Jin Yang Pharmaceutical had annual revenue of 120.69B KRW with 6.49% growth. Jin Yang Pharmaceutical had revenue of 30.32B in the quarter ending December 31, 2025, with 13.05% growth.
Revenue
120.69B
Revenue Growth
+6.49%
P/S Ratio
0.50
Revenue / Employee
548.57M
Employees
220
Market Cap
60.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 120.69B | 7.35B | 6.49% |
| Dec 31, 2024 | 113.33B | 19.22B | 20.42% |
| Dec 31, 2023 | 94.11B | 17.85B | 23.40% |
| Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
| Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmax Nbt | 287.48B |
| Korea Arlico Pharm | 205.21B |
| RP Bio | 134.21B |
| Sinsin Pharmaceutical | 110.29B |
| GeneBioTech Co. ,Ltd | 92.28B |
| Sinil Pharmaceutical | 80.56B |
| Korean Drug | 62.51B |
| Kyung Nam Pharm | 56.18B |